Comparison of effectiveness of epidural analgesia and monitored anesthesia care for high-intensity focused ultrasound treatment of adenomyosis
article
OA: hybrid
CC0
⤵ 3 in-corpus citations
AI-generated summary
Epidural analgesia provided superior pain control and ablation efficiency compared to monitored anesthesia care during high-intensity focused ultrasound treatment for adenomyosis, with reduced opioid use.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: High-intensity focused ultrasound (HIFU) is a noninvasive thermodestructive procedure targeting internal organs with concentrated sonification energy that may cause pain. We aimed to compare the effectiveness of epidural analgesia (EA) and monitored anesthesia care (MAC) in HIFU treatment of uterine adenomyosis. MATERIALS AND METHODS: Sixty-eight patients were included in this case-control study. Thirty-seven patients underwent MAC; 31 patients underwent fluoroscope-guided epidural analgesia. The primary outcome was a frequency of patients reporting severe or very severe intraoperative pain. Secondary outcomes were differences in dosages of analgesics, ablation ratio, and other clinical factors. RESULTS: The EA group reported a significantly lower frequency of severe or very severe intraoperative pain than did the MAC group (41.9% vs. 75.7%; p = .006). Consumption of remifentanil during treatment was significantly lower in the EA group (173 ± 189 µg vs. 426 ± 380 µg; p = .001), as was the use of fentanyl in the recovery room (52 ± 38 µg vs. 75 ± 44 µg; p = .030). Multivariable analysis revealed EA to be the largest contributing factor to increased nonperfused volume ratio (B = 0.41; 95% confidence interval = 0.29 to 0.53; p < .001). The frequency of thermal injury after HIFU was significantly lower in the EA group (22.6% vs. 54.1%; p = .008). CONCLUSIONS: EA during HIFU treatment of uterine adenomyosis improved quality of pain control and ablation ratio over MAC without increasing risk of treatment-related complications. EA also reduced consumption of opioid analgesics during and after HIFU treatment.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center 2010
- Safety and Efficacy of High Intensity Focused Ultrasound Ablation Therapy for Adenomyosis 2009
- Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study 2016
- Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study 2015
Cited by (3)
- High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects 2024
- Optimized treatment parameter by computer simulation for high-intensity focused ultrasound treatment of uterine adenomyosis: Short-term and long-term results 2024
- Effect of Paracervical Block Before Ultrasound Guided High Intensity Focused Ultrasound Treatment in Uterine Fibroids and Adenomyosise 2022
References (38)
- Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study via openalex
- Safety and Efficacy of High Intensity Focused Ultrasound Ablation Therapy for Adenomyosis via openalex
- Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center via openalex
- Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study via openalex
- W1965153349 via openalex
- W1971932770 via openalex
- W1974160564 via openalex
- W1980699634 via openalex
- W1982460292 via openalex
- W1983586083 via openalex
- W1996880858 via openalex
- W2016975980 via openalex
- W2019103299 via openalex
- W2021318743 via openalex
- W2028137916 via openalex
- W2043088579 via openalex
- W2048002169 via openalex
- W2048944905 via openalex
- W2060489231 via openalex
- W2061388116 via openalex
- W2083054657 via openalex
- W2085131028 via openalex
- W2085711913 via openalex
- W2088499309 via openalex
- W2103442479 via openalex
- W2110647243 via openalex
- W2136267489 via openalex
- W2155504753 via openalex
- W2319109232 via openalex
- W2517769867 via openalex
- W2580707514 via openalex
- W2846621826 via openalex
- W4230358652 via openalex
- W1490368871 via openalex
- W4412908346 via openalex
- W1880728045 via openalex
- W1895092234 via openalex
- W1920367505 via openalex
Cited by (3)
- Optimized treatment parameter by computer simulation for high-intensity focused ultrasound treatment of uterine adenomyosis: Short-term and long-term results 2024
- High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects 2024
- Effect of Paracervical Block Before Ultrasound Guided High Intensity Focused Ultrasound Treatment in Uterine Fibroids and Adenomyosise 2022
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:19:31.300640+00:00
License: CC0
· commercial use OK